New York, New York (PRWEB) August 31, 2013
Thousands of Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) filed on behalf of patients who developed bladder cancer that may be related to long-term use of the Type 2 diabetes drug continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to court documents, the most recent Status Conference in the litigation was convened on August 22, 2013, at which time a number of issued were addressed, including the status of state and federal Actos lawsuits, and preparations for the proceeding’s bellwether trials. More than 2,500 Actos bladder cancer claims are currently pending in the Western District of Louisiana, where the first trials are scheduled to begin in January. (In re: Actos Product Liability Litigation, MDL No. 2299)
“Our Firm receives inquiries on a regular basis from individuals seeking to file an Actos bladder cancer lawsuit. We are not at all surprised that the number of claims filed in Louisiana has surpassed 2,500, and look forward to additional progress in the proceeding in the coming months,” says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos lawsuit evaluations to patients who developed bladder cancer after using the medication for an extended period of time.
Actos Bladder Cancer Lawsuits
All of the lawsuits pending in the Western District of Louisiana accuse Takeda Pharmaceuticals of concealing knowledge that use of the Type 2 diabetes treatment was associated with an increased risk of bladder cancer, and failing to provide adequate warnings to patients and doctors regarding this risk. The litigation was established in December 2011, after the U.S. Food & Drug Administration (FDA) warned the previous June that use of Actos for more than one year had been associated with a significant increase in the risk for bladder cancer. According to Bloomberg.com, Actos was also pulled from the market in Germany and France that month because of its association with bladder cancer.*
Additional Actos bladder cancer lawsuits have also been filed in various federal courts around the country. In April, the nation’s first trial involving Actos bladder cancer allegations ended with a Los Angeles Superior Court jury awarding $6.5 million to a plaintiff who was diagnosed with the disease after taking Actos for four years. However, the judge overseeing the case granted Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Actos patients who were diagnosed with bladder cancer may be entitled to compensation for medical bills, lost wages and other damages related to their illness. Learn More about filing an Actos bladder cancer lawsuit by visiting Bernstein Liebhard LLP’s website. For additional information, please contact Bernstein Liebhard LLP today by calling 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/actos-lawsuit/actos-bladder-cancer/prweb11079665.htm.
Copyright©2012 Vocus, Inc.
All rights reserved